Description: From depression to Paralympian. This is a story about overcoming odds, being grateful for the people around you ...

A new study is providing a clearer picture of the genetic landscape of major depression, revealing that the disorder may have ...

New research suggests that microdosing a popular psychedelic may provide relief for people struggling with major depressive ...

The U.S. Food and Drug Administration has approved Caplyta (lumateperone) as an adjunctive therapy with antidepressants for ...

The brain drug developer plans to slash R&D expenses by about 60% in the wake of the FDA surprisingly rejecting its rare disease drug Vyglxia.

In short, actively seek out something to smile about—even if the smile feels forced. According to Allyson Pimentel of the ...

The Ali Forney Center has ambitious plans for its future. The charity operates a drop-in shelter for LGBTQ+ youths in Manhattan, where more than 2,200 young people per year seek medical attention, ...

17 abstracts from across the Company's portfolio and pipeline highlight new clinical and real-world data on major depressive disorder and treatment-resistant depression New post-hoc analysis of ...

Before Chelsea signed Jamie Gittens from Borussia Dortmund this summer, we were told that he was something of a “project” that would need some work. Even despite that, we probably underestimated how ...

Soft drink consumption is linked to a higher risk for major depressive disorder (MDD) and more severe symptoms in women, potentially due to alterations in the gut microbiome, new research showed.